19
Participants
Start Date
April 24, 2015
Primary Completion Date
June 26, 2019
Study Completion Date
June 26, 2019
Ages 7-11
Oral/Capsule, once per day or twice per day dosing; Treatment duration consists of a 1 to 4 week Conversion/Titration Phase leading to a 2 to 6 week Maintenance Treatment duration.
ages 12-17
Oral/Capsule, once per day or twice per day dosing; Treatment duration consists of a 1 to 4 week Conversion/Titration Phase leading to a 2 to 6 week Maintenance Treatment duration.
East Carolina University Brody School of Medicine(ECU), Greenville
Leo Jenkins Cancer Center Pharmacy Attn: Rebecca Turnage, Greenville
Veritas Research Corp., Miami Lakes
Holtz Children Hospital/Jackson Memorial Hospital, Miami
Jackson Memorial Hospital - Pharmacy Department Basement West, Miami
Sylvester Comprehensive Cancer Center-Alex's Place, Miami
University of Miami / Jackson Memorial Hospital, Miami
Nicklaus Children's Hospital, Miami
University of Illinois at Chicago Clinical Research Center, Chicago
University of Illinois at the Med Center, University of Illinois, Chicago
University of Illinois Hospital and Health Sciences System, Chicago
Primary Children's Hospital Outpatient Services, Salt Lake City
Primary Children's Hospital, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
Gottschalk Medical Plaza, Irvine
The University of California, Irvine Health - Medical Specialties, Orange
UCI Medical Center- Outpatient Pharmacy, Orange
University of California, Irvine Health-Inpatient Pharmacy, Orange
University of California, Irvine Health-Medical Specialties, Orange
Lead Sponsor
Pfizer
INDUSTRY